Annovis Bio Inc
ANVS
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.43M
Close$
$0.95
50% downside
Current Fair Value
50% downsideOvervalued by 50% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.43 Million |
|---|---|
| Enterprise Value | $-14,184,652,174.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.4 |
| Beta | 1.19 |
| Outstanding Shares | 27,848,000 |
Return
| Return on Equity | -796.05% |
|---|---|
| Return on Assets | -153.20% |
| Return on Invested Capital | -210.79% |
Valuation & Multiples
| P/E Ratio | -1.02 |
|---|---|
| PEG | -0.47 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.95 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 58.93% |
|---|---|
| Total Calls | 10,000▼ 96.97% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.84%▼ 16.12% |
|---|---|
| Total Invested | $434,928▼ 95.87% |
| Investors Holding | 14▼ 48.00% |
ESG Score
No data
About Annovis Bio Inc
CEO: Maria Maccecchini